Citace podle APA (7th ed.)

Rejdak, K., & Grieb, P. (2020). Adamantanes might be protective from COVID-19 in patients with neurological diseases: Multiple sclerosis, parkinsonism and cognitive impairment. Multiple sclerosis and related disorders, 42, 102163. https://doi.org/10.1016/j.msard.2020.102163

Citace podle Chicago (17th ed.)

Rejdak, Konrad, a Paweł Grieb. "Adamantanes Might Be Protective from COVID-19 in Patients with Neurological Diseases: Multiple Sclerosis, Parkinsonism and Cognitive Impairment." Multiple Sclerosis and Related Disorders 42 (2020): 102163. https://doi.org/10.1016/j.msard.2020.102163.

Citace podle MLA (9th ed.)

Rejdak, Konrad, a Paweł Grieb. "Adamantanes Might Be Protective from COVID-19 in Patients with Neurological Diseases: Multiple Sclerosis, Parkinsonism and Cognitive Impairment." Multiple Sclerosis and Related Disorders, vol. 42, 2020, p. 102163, https://doi.org/10.1016/j.msard.2020.102163.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..